*By Max Godnick* Roughly three months remain until the 91st Academy Awards, and if you're lucky, you might be able to squeeze in one Oscar contender per weekend before the big night. Award season is in full swing this month with a crowded slate of contenders jockeying for adoration from audiences and critics alike. The race begin in earnest last month with the release of Bradley Cooper's [memeable] (https://www.billboard.com/articles/news/8477323/a-star-is-born-best-memes) epic, "A Star Is Born." With a box-office haul of $259 million and counting, the musical (a remake of a remake of a remake) is a true juggernaut and has firmly established itself as the front runner in the vaunted Best Picture (and Director, and Actor, and Actress, and Supporting Actor, and Original Song) category. With the race heating up by the week, Cooper and Lady Gaga will be fortunate to maintain their front-runner status by months' end ー [they're far from the shallow now](https://www.youtube.com/watch?v=bo_efYhYU2A). Julian Roman, a critic and contributing editor at MovieWeb, joined Cheddar on Friday to preview some of November's most anticipated new flicks. **"Bohemian Rhapsody" (20th Century Fox):** Another one bites the dust. The Freddie Mercury biopic's [long road](http://www.vulture.com/2018/11/bohemian-rhapsody-chaotic-eight-year-odyssey-to-the-screen.html) to the big screen landed with a critical thud, garnering mixed reviews for its depiction of Queen's rise to arena-rock fame. But, audiences looking for somebody to love need only look to leading man Rami Malek ("Mr. Robot") for a bright spot in this jukebox film. The actor is getting raves for his turn as the mustachioed music icon and is a good bet as a Best Actor nominees. He is the champion, the movie alas is not. (Nov. 2) *Roman's Take:* "I think the film will do very well. I thought it was great, very entertaining. A lot of the people who didn't like it want it to have more salacious details regarding Mercury's homosexuality. The film doesn't really dive that deep but it has a lot of music ... it moves quickly, I think it's going to be a big hit." **"Roma" (Netflix):** Netflix ($NFLX) is going where it's never gone before: the movie theater. The streaming platform [veered](https://www.hollywoodreporter.com/news/netflix-give-3-award-contenders-runs-select-theaters-1153081) from its long-held position of streaming over everything when it agreed to theatrical releases for three of its movies. Chief among them is "Roma," Alfonso Cuarón's ("Gravity") black-and-white homage to Mexico City featuring a mostly-unknown cast. The film is Netflix's best shot at its first Best Picture nomination, an honor the company so desperately is coveting ー that it's willing to set aside its small-screen loyalty to court more traditionalist Academy members. If anything can dull Cooper's "Star" this month, "Roma" is the one to watch. (Nov. 21) *Roman's Take:* "I don't think Netflix really cares how much money this makes at the box office. They just want the movie released so it's going to qualify for Oscars. They want the awards, they want the big film-making season where everyone's wearing nice dresses and they're going to big premieres. This is what Netflix wants, they want the prestige of the big studios." **"Green Book" (Universal):** Before sequels and superheroes took over the box office, mid-budget, four-quadrant crowd-pleasing dramas used to be the defining genre for Oscar bait. Universal hopes to bring the format back to the forefront with "Green Book," a low-key story about a Jamaican-American pianist and his New York driver's tour of the Deep South in the 1960s. After making noise on the festival circuit, the studio is aiming to turn a word-of-mouth campaign into the season's sleeper contender. Viggo Mortensen stars alongside Mahershala Ali ("Moonlight") who's out to win his second Best Supporting Actor trophy in just three years. (Nov. 16) *Roman's Take:* "I think this is the sleeper hit of the season. I think this film is going to be a big box-office hit and very big at the awards as well... The movie is being called the reverse of 'Driving Miss Daisy' but that's way too simple to put this movie in that box." **"Widows" (20th Century Fox):** "Oceans 8" disappointed both critically and commercially when it failed to break the bank this summer. But gender-bending twists on the classic heist format get another chance this month with "Widows," director Steve McQueen's first movie since the 2012 awards darling "12 Years a Slave." The film stars Viola Davis, Michelle Rodriguez, Cynthia Erivo, and Elizabeth Debicki as the quartet of titular widows who pick up where their deceased husband's left off in a heist gone wrong. It's based on a British series from the 1980s of the same name and penned by "Gone Girl" writer Gillian Flynn. If the Oscars want to pay tribute to the year-long referendum on women in Hollywood, this would be a good place to start. (Nov. 16) *Roman's Take:* "I'm expecting greatness... This is a big cast, a great director, and great writing, so I have really high hopes." **"Creed II" (MGM):** If any November blockbuster stands a puncher's chance of landing on Oscar ballots, it's "Creed II." Michael B. Jordan returns opposite Sylvester Stallone in the sequel to 2015's hit "Rocky" spin-off. The boxing franchise enters its fifth decade every bit the phenomenon it once was. Since his star-making turn three years ago, Jordan has grown into one of Hollywood's most bankable leading men. After helping "Black Panther" become the eighth highest-grossing movie of all time earlier this year, the star's earning power will be put to the test again over Thanksgiving weekend. In the sequel, Creed finds himself up against the son of former Rocky foe Ivan Drago. No matter who hits the mat first this time, the movie seems destined to be a winner. (Nov. 21) *Roman's Take:* "I'm afraid it might fall a little bit flat where it comes to 'sequelitis' as I call it, and lacking originality. Now , Michael B. Jordan is a tremendous actor, Sylvester Stallone a tremendous actor, so I hope it's more dramatic and not just fluff."

Share:
More In Culture
U.S. Stocks Close Mixed as Nasdaq Closes at Session High
Markets closed the day mixed, and well off their lows of the day following a market meltdown earlier in the session. The Nasdaq staged a comeback late in the day, even amid ongoing worries about the Federal Reserve raising interest rates. Doug Flynn, certified financial planner and co-founder of Flynn Zito Capito, joined Cheddar News' Closing Bell to discuss the markets' close and what's driving the major indexes.
CrossTower Partners With BankProv to Provide Crypto Lending Platform
Two companies recently announced a new partnership aimed at addressing the growing demand to borrow against crypto - digital assets capital markets firm CrossTower is partnering with commercial bank, BankProv. The companies are launching a crypto lending platform that will allow Bitcoin miners to receive loans to invest in crypto mining equipment. The companies say the program also addresses the difficulty of breaking into crypto mining due to the high cost. CrossTower research analyst Martin Gaspar joins Cheddar News' Closing Bell to discuss.
Break the Love Raises $2.5 Million Seed Funding Round to Get People Playing Tennis
Next-gen social sports platform Break the Love recently raised $2.5 million in seed funding. Break the Love's platform and iOS app allows users to discover and book group-based tennis activities, to either learn, train, or compete. The new company has already gotten support from a few big names in the world of tennis, including the coach of Naomi Osaka, as well as the United States Tennis Association and the brand Wilson. Break the Love founder and CEO Trisha Goyal joins Cheddar News' Closing Bell to discuss.
Nurses Call For Protection For HealthCare Workers
As the Omicron variant continues to sweep across the country. The US Supreme Court is expected to hear arguments at the end of this week on whether or not the Biden administration can force private companies to vaccinate or test millions of their employees. In addition, the National Nurses United has spearheaded legal action to protect nurses and health care workers, patients, and the public while on the job. President of the National Nurses Union, Zenei Cortez, joined Cheddar to discuss more.
China Crackdown on "Sissy Men"
China's ongoing crackdown of its own entertainment industry has been raising eyebrows for once now. With the ruling Communist Party instructing media companies to boycott immoral and overly entertaining stars. But the country has gone even further. Now experts warn that this could lead to further issues such as gender-based violence. Professor at the Institute of Sociology at National Tsinghua University, Hsiu-Hua Shen, and Associate Professor of Politics at Keough School of Global Affairs at the University of Notre Dame Joshua Eisenman, joined Cheddar to discuss more.
Lawmakers Reflect Back on January 6th Capitol Riots
Today marks one year since the January 6 Attack on the United States Capitol. The Country watched as supporters of then-President Trump stormed what was assumed to be the most secure building in the country in an attempt to stop the certification of the 2020 Election. Several lawmakers, including the Vice President, could be seen ducking down as they feared for their lives. Democratic Michigan Representative Dan Kildee, joined Cheddar to discuss more.
Bed Bath & Beyond's Stock Jumps Despite Earnings Miss as Meme Stock Mania Reappears
Bed Bath & Beyond delivered disappointing fiscal third-quarter results for 2022. Shares initially dove more than 9% in premarket trading on the news but finished the day up nearly 8%. Bed Bath & Beyond has been a meme-stock target for online investors in the past -- so was meme-stock mania a factor in the recent stock movement for the company? Jaime Rogozinski, the founder of the subreddit WallStreetBets, joins Cheddar News' Closing Bell for more, as his forum helped spark the meme stock phenomena. He also discussed some decentralized finance services and trends for the retail investor to watch for in 2022.
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Load More